Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-229169
Filing Date
2021-07-29
Accepted
2021-07-29 16:02:09
Documents
3
Period of Report
2021-07-29

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d591999d6k.htm 6-K 7728
2 EX-99.1 d591999dex991.htm EX-99.1 12841
3 GRAPHIC g591999g88w32.jpg GRAPHIC 4647
  Complete submission text file 0001193125-21-229169.txt   28189
Mailing Address SUITE 802, WEST TOWER, OMNLVISION 88 SHANGKE ROAD, PUDONG DISTRICT SHANGHAI F4 201210
Business Address SUITE 802, WEST TOWER, OMNLVISION 88 SHANGKE ROAD, PUDONG DISTRICT SHANGHAI F4 201210 862160578000
I-Mab (Filer) CIK: 0001778016 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39173 | Film No.: 211127318
SIC: 2834 Pharmaceutical Preparations